Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rodrigo Rivera
Institutions:
Pontificia Universidad Católica de Valparaíso,
aTyr Pharma (United States)
Observed institutions:
Pontificia Universidad Católica de Valparaíso,
aTyr Pharma (United States)
ORCID:
0000-0002-8247-7448
Observed ORCID:
0000-0002-8247-7448
OpenAlex ID:
A5063660807
A high throughput bispecific antibody discovery pipeline
2023
·
Aude I. Segaliny
, Jayapriya Jayaraman
, et al.
·
Communications Biology
·
29
PDF
Abstract 6014: A new generation of Tumor Microenvironment Activated Therapeutic (T-MATE) targeting solid tumors
2025
·
Xiaoya Ma
, Yang Zhou
, et al.
·
Cancer Research
·
2
Visualizing Electric Fields Using Rubbed Balloons as the High-Voltage Source
2024
·
Francisco Vera
, Manuel Ortiz
, et al.
·
The Physics Teacher
·
2
Abstract 2644: Enhancing safety to unlock efficacy: A novel class of conditionally-activated T cell engagers for solid tumors.
2026
·
Aude Segaliny
, Than Thar Aye
, et al.
·
Cancer Research
·
1
Using LEDs to build a simple polarity detector
2025
·
Francisco Antonio Horta-Rangel
, Francisco Vera
, et al.
·
Physics Education
·
1
PDF
A 3D printed electrostatic kit
2026
·
Francisco Vera
, Manuel Ortiz
, et al.
·
Physics Education
PDF
1155 ABS-101, a novel class of tumor-activated CD3xTROP2 T cell engager for solid tumors
2024
·
Yang Zhou
, Xiaoya Ma
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
7
Citation count:
35
H-index:
2
I10-index:
1
Year
Topic
Type